Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.
about
Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous NephropathyMembranous nephropathy: not just a disease for adultsAntiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous NephropathyGlomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI.Membranous nephropathy: from models to manThe diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis.Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis.American Society of Nephrology quiz and questionnaire 2014: glomerular diseasesGlomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens.Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy.Membranous Nephropathy: The Journey Continues …Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study.Changing the concepts of immune-mediated glomerular diseases through proteomics.Primary glomerulonephritis: A review of important recent discoveries.Membranous nephropathy: Pilot study of a novel regimen combining cyclosporine and Rituximab.Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.Glomerular diseases: membranous nephropathy--a modern viewThe role of complement in membranous nephropathy.B-cell-targeted therapy in adult glomerulonephritis.Immunopathogenesis of membranous nephropathy: an update.Recent advances in the understanding of immune-mediated nephrotic syndrome: diagnostic and prognostic implications.Immunology of membranous nephropathy: from animal models to humans.Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms.Membranous nephropathy in the kidney allograft.A Proposal for a Serology-Based Approach to Membranous Nephropathy.A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy.Low-dose rituximab is poorly effective in patients with primary membranous nephropathy.Circulating antibodies to α-enolase and phospholipase A2 receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy.Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy.In reply to "Anti-alpha-enolase antibodies in membranous nephropathy: isotype matters".Can genetics risk-stratify patients with membranous nephropathy?Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues.Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach.Mouse models of membranous nephropathy: the road less travelled by.What is the role of rituximab in idiopathic membranous nephropathy?Proteinuria in membranous lupus nephritis: the pathology is in the podocyte.Complement-Mediated Glomerular Diseases: A Tale of 3 Pathways.BAFF and APRIL expression as an autoimmune signature of membranous nephropathy.Detection and clinical significance of glomerular M-type phospholipase A2 receptor in patients with idiopathic membranous nephropathy.
P2860
Q26747416-B1262A97-A9AB-4048-AE79-6459AD6A4F88Q26866206-6AEDA8A9-39AA-46D2-BF59-F6CC9A82EA30Q27023372-3675CA1A-E132-4DF5-A07E-FAFAC2666DDDQ30596600-810C4EAB-3C47-4618-B16C-AB732945BF01Q33872569-DDE17CB8-B836-47F5-AF07-1352BDEA9D41Q34066574-F67D4C0B-54BF-459C-BA48-AD46C3206AC5Q35148727-F5B44CD9-3276-48D7-951E-EB4C0CE06ADAQ35278674-724ED52E-9F49-4D32-AA59-5604B4BD64C4Q35422370-03685CEB-0DBA-42AD-BA3B-A39E1FBEA1E9Q35754366-CC687BCC-82BE-4C78-A8C3-CFA3B65632F9Q35800770-9B3DB8AC-2CF0-4D44-8C14-0131C5DD5AE4Q36063886-74D3FC93-ACFF-4CEE-A2CF-31BE1FA2C0DEQ36088887-F1A5F5A3-B11E-4AF5-B156-EDE02044EB44Q36201993-8C4C5E96-66EB-45AA-88AD-B3F53D795AA3Q36465902-936506A1-5271-476E-AE42-9BBC232D1F35Q37475696-D8BB6AB7-5414-46D7-8B78-36C0F5DADFDBQ37665145-BBE56ED7-7C98-4DC9-8DDA-159C89395D75Q38118221-CD465D80-C0DB-4706-9B4C-2D86AFBD789BQ38155652-D7C8761A-582B-4E76-8F14-C29076BD2C9DQ38159787-B2E33932-C06C-4243-A7BD-D6CA04275C29Q38203172-74DF0F49-4301-43BE-97DF-CAA4BEE208A7Q38371343-1332491F-9252-48FD-9B7F-3EBB1D9BB64AQ38605469-3AC50DB0-A976-4E00-A17F-7B152F8A48B9Q38711526-EBC87294-FB6D-445F-A32A-6E1FD180A3C4Q38959093-89D2AF07-D854-4AD0-96FF-D1180F7799F3Q38989854-15BF3C07-2E9B-4196-A07A-5256E6AAEF47Q40054212-515D0ADA-B6B7-4FF4-AB1D-E37288AF5C3BQ40663445-886B991C-FF30-48DD-B561-2549098DBC7AQ40810605-0457D95E-F28E-43D9-A82A-5BBB4FCC0BEEQ41622450-4AAC6309-0B95-46F9-8016-F8BE555ECDCBQ41900895-81A6AEF7-7AF7-4475-A124-9EEA2F5C8DF9Q42543471-9DC66546-5C28-4540-B2B8-8156CD34651EQ42588842-235F8A74-58F5-4E31-B91D-63DBECD56B3DQ42772431-86DC0A03-7F97-456C-90C7-A37FF71E77A5Q43087986-990BF442-34FC-4C59-9F63-DFCF43EC0766Q45351919-0F946BE1-A124-46C5-AF84-1428BA5588BEQ46141201-B42C2687-29BE-4841-AD60-825B4D46FCC9Q47108030-BD839723-C151-44AB-B1A4-70E47B20C235Q49208897-7D89DCAE-6DD4-41DE-BD12-C1AD9A01DBF0Q51554333-2816CABF-1EAF-4FA5-B508-542BC2FCE542
P2860
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.
@ast
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.
@en
type
label
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.
@ast
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.
@en
prefLabel
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.
@ast
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.
@en
P2093
P2860
P50
P356
P1476
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy
@en
P2093
Andrea Magnano
Corrado Murtas
Fernando C Fervenza
Francesca Bruno
Francesco Scolari
Landino Allegri
Lucia Argentiero
Luciana Furci
Maria Luisa Carnevali
Piergiorgio Messa
P2860
P304
P356
10.2215/CJN.02170312
P50
P577
2012-07-05T00:00:00Z